Tavaborole

(Kerydin)

Tavaborole

Drug updated on 11/10/2023

Dosage FormSolution (topical: 5%)
Drug ClassOxaborole antifungals
Ongoing and Completed StudiesClinicalTrials.gov

Indication

  • For the topical treatment of onychomycosis of the toenails due to Trichophyton rubrum or Trichophyton mentagrophytes.

Product Monograph / Prescribing Information

Document TitleYearSource
Kerydin (tavaborole) Prescribing Information.2018FDA

Systematic Reviews / Meta-Analyses

Document TitleYearSource
Topical and device-based treatments for fungal infections of the toenails (review). 2020Cochrane Database of Systematic Reviews